TY - JOUR
T1 - Effect of the ouabain-quinidine interaction of left ventricular and left atrial function in conscious dogs
AU - Goldman, S.
AU - Hager, W. D.
AU - Olajos, M.
AU - Perrier, D.
AU - Mayersohn, M.
PY - 1983
Y1 - 1983
N2 - The effect of the ouabain-quinidine interaction was examined in 10 conscious dogs. Left ventricular (LV) pressure, LV dP/dt, LV diameter and left atrial (LA) diameter were measured with high-fidelity micromanometers and sonomicrometer crystals. Ouabain, 0.025 mg/kg, significantly (p < 0.05) increased LV dP/dt, LV and LA fractional shortening and LV and LA velocity of circumferential fiber shortening (Vcf). In a separate experiment, quinidine was administered as a bolus dose, 3.85 mg/kg, followed by an infusion, 0.28 mg/kg/min. This resulted in steady-state quinidine concentrations that produced no change in wall motion or hemodynamics. When ouabain was given 1 hour into the quinidine infusion, only LV dP/dt increased significantly (p < 0.05). Ouabain alone increased LV dP/dt 26.4 ± 3.5%, whereas ouabain during the quinidine infusion increased it by 9.5 ± 2.3%. Similar differences were seen in the response to ouabain in the absence and presence of quinidine: LV Vcf, 22.4 ± 4.9% vs 6.0 ± 2.1%, LV fractional shortening, 23.1 ± 4.6% vs 5.8 ± 2.1%, LA Vcf, 22.7 ± 5.9 vs 4.6 ± 2.0% and LA fractional shortening, 21.8 ± 7% vs 7.8 ± 3.3%. Thus, in the presence of quinidine the increase in intropy usually seen with ouabain was markedly attenuated. These data suggest that the quinidine-induced increase in digoxin serum concentrations is accompanied by a decrease in the contractile response of the heart to digoxin.
AB - The effect of the ouabain-quinidine interaction was examined in 10 conscious dogs. Left ventricular (LV) pressure, LV dP/dt, LV diameter and left atrial (LA) diameter were measured with high-fidelity micromanometers and sonomicrometer crystals. Ouabain, 0.025 mg/kg, significantly (p < 0.05) increased LV dP/dt, LV and LA fractional shortening and LV and LA velocity of circumferential fiber shortening (Vcf). In a separate experiment, quinidine was administered as a bolus dose, 3.85 mg/kg, followed by an infusion, 0.28 mg/kg/min. This resulted in steady-state quinidine concentrations that produced no change in wall motion or hemodynamics. When ouabain was given 1 hour into the quinidine infusion, only LV dP/dt increased significantly (p < 0.05). Ouabain alone increased LV dP/dt 26.4 ± 3.5%, whereas ouabain during the quinidine infusion increased it by 9.5 ± 2.3%. Similar differences were seen in the response to ouabain in the absence and presence of quinidine: LV Vcf, 22.4 ± 4.9% vs 6.0 ± 2.1%, LV fractional shortening, 23.1 ± 4.6% vs 5.8 ± 2.1%, LA Vcf, 22.7 ± 5.9 vs 4.6 ± 2.0% and LA fractional shortening, 21.8 ± 7% vs 7.8 ± 3.3%. Thus, in the presence of quinidine the increase in intropy usually seen with ouabain was markedly attenuated. These data suggest that the quinidine-induced increase in digoxin serum concentrations is accompanied by a decrease in the contractile response of the heart to digoxin.
UR - http://www.scopus.com/inward/record.url?scp=0020615170&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020615170&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.67.5.1054
DO - 10.1161/01.CIR.67.5.1054
M3 - Article
C2 - 6831670
AN - SCOPUS:0020615170
SN - 0375-9474
VL - 67
SP - 1054
EP - 1058
JO - Unknown Journal
JF - Unknown Journal
IS - 5
ER -